Yan Yin's Form 4 filing
Bio Essence Corp (BIOE) · filed Jul 17, 2024
- Accession no.
- 0001213900-24-062097
- Filed
- Jul 17, 2024
- Trade date
- Jul 2-5, 2024
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $484.2K. It was filed 15 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001213900-24-086923 (Oct 10, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan YinCIK 0001990397 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | Common Stock | SSaleDisposed | −50,000 | $7.83 | −$391,500 | 18,950,000 | Direct | |
| Jul 3, 2024 | Common Stock | SSaleDisposed | −4,065 | $8.96 | −$36,422.4 | 18,945,935 | Direct | |
| Jul 5, 2024 | Common Stock | SSaleDisposed | −6,209 | $9.07 | −$56,315.63 | 18,939,726 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.